Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

Inclusion Criteria: * Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms; * Male participants aged 18 years or more; * Sexually active participants with a defined partner who have averaged 1 attempt at sexual intercourse per week in the past month; * Diagnosis of Benign Prostatic Hyperplasia; * Diagnosis of erectile dysfunction; * Patients with score between 6 and 25 points in the erectile function questionnaire; * IPSS (International Prostate Symptom Score) greater or equal to 8 points; Exclusion Criteria: * Known hypersensitivity to the formula components used during the clinical trial; * History of alcohol and/or substance abuse within 2 years; * Diagnosis of other diseases or conditions in the urinary tract, including but not limited to: cancer, neurogenic bladder; urinary incontinence, recurrent infection, urethral stricture, bacterial prostatitis; * Clinical evidence of prostate cancer; * Hypogonadism or absent sexual desire; * Severe psychiatric or psychosocial disorders; * Primary erectile dysfunction; * Polyneuropathy, neurodegenerative diseases, trauma or spinal cord injuries, central nervous system tumors or other conditions that may affect erections; * Anatomical penile deformation that can significantly impair erection, including but not limited to: angulation, cavernous fibrosis, Peyronie's disease.